Northwest & Ethical Investments L.P. Moderna, Inc. Transaction History
Northwest & Ethical Investments L.P.
- $3.69 Trillion
- Q1 2025
A detailed history of Northwest & Ethical Investments L.P. transactions in Moderna, Inc. stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 22,462 shares of MRNA stock, worth $736,528. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,462
Previous 43,466
48.32%
Holding current value
$736,528
Previous $1.81 Billion
64.77%
% of portfolio
0.02%
Previous 0.05%
Shares
10 transactions
Others Institutions Holding MRNA
# of Institutions
864Shares Held
255MCall Options Held
24MPut Options Held
31.3M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.32 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$838 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$818 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$583 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$245 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $12.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...